Indirect-Response PK/PD Models
Learn how indirect-response PK/PD models describe delayed or sustained drug effects by modeling drug-driven changes in response production or loss, including the four classic model types, equations, assumptions, parameter interpretation, and a worked example.
Indirect Response Stimulation Models
Learn how indirect response stimulation models describe drug effects that increase the production or appearance of an endogenous response, including model structure, parameters, worked examples, and PK/PD interpretation.
Indirect Response Inhibition Models
Learn how indirect response inhibition models describe drug effects that reduce the production or formation of a response, including Imax and IC50 models, turnover dynamics, steady state, and delayed pharmacodynamic effects.
Hysteresis in PK/PD Relationships
Learn how hysteresis explains delayed or time-dependent pharmacodynamic effects, including clockwise and counterclockwise hysteresis, effect-site models, tolerance, and PK/PD interpretation.
Hill and Sigmoid Emax Models
Learn how Hill and sigmoid Emax models describe nonlinear exposure-response relationships, interpret Emax, EC50, and the Hill coefficient, and use the model for pharmacodynamic analysis.
Exposure-Response Safety Modeling
Learn how exposure-response safety modeling connects drug exposure to adverse events, laboratory abnormalities, vital signs, ECG findings, and other safety outcomes in clinical drug development.
Exposure-Response Relationships
Learn how exposure-response relationships connect drug exposure to pharmacodynamic outcomes, including Emax models, EC50, exposure metrics, model selection, interpretation, and clinical applications.
Exposure-Response Modeling for Dose Selection
Learn how exposure-response modeling connects drug exposure to efficacy and safety and how PK/PD models, population analyses, and simulations can support dose selection during drug development.
Exposure-Response Efficacy Modeling
Learn how exposure-response efficacy modeling connects pharmacokinetic exposure to pharmacodynamic and clinical efficacy outcomes, including Emax models, dose-response relationships, covariates, model interpretation, and clinical development applications.
Exposure-Response Analysis for QTc
Learn how exposure-response analysis links drug concentration to QTc changes, how concentration-QTc mixed-effects models are constructed, how to evaluate hysteresis and model adequacy, and how model-based QTc effects are interpreted in clinical drug development.